TY  - GEN
AU  - Lieberman,R
AU  - Nelson,W G
AU  - Sakr,W A
AU  - Meyskens,F L
AU  - Klein,E A
AU  - Wilding,G
AU  - Partin,A W
AU  - Lee,J J
AU  - Lippman,S M
TI  - Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations
SN  - 1527-9995
PY  - 2001///0607
KW  - Anticarcinogenic Agents
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Biomarkers, Tumor
KW  - Clinical Trials as Topic
KW  - Drug Industry
KW  - Government
KW  - Humans
KW  - Interinstitutional Relations
KW  - Male
KW  - Middle Aged
KW  - National Institutes of Health (U.S.)
KW  - Practice Guidelines as Topic
KW  - Prostatic Neoplasms
KW  - prevention & control
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Congress
UR  - https://doi.org/10.1016/s0090-4295(00)00931-6
ER  -